The latest research, clinical data and innovations in ophthalmology were presented at the 2017 Annual Meeting of the American Academy of Ophthalmology (AAO) in New Orleans, USA, held on 11−14 November 2017. As in previous years, an international panel of renowned ophthalmologists were supported by Pfizer to attend the meeting and contribute articles to create the Eye on AAO 2017 e-Bulletins. Delivered immediately after each meeting day, and developed with full editorial independence, these e-bulletins feature conference highlights of the latest research, hot topics in ophthalmology and their relevance to the Asia Pacific region.
The e-Bulletins are now collected together and available for download from this page; they are sure to be of significant interest to those seeking the latest advances in ophthalmology.
At the recent Alcon launch symposium of Systane® Hydration in Kuala Lumpur, three prominent speakers shared their experiences on the management of ocular dryness and highlighted the role of the new therapy.
The 2016 Annual Meeting of the American Academy of Ophthalmology (AAO) was held in Chicago, USA, from 15−18 October 2016. A panel of renowned international clinicians in the field of ophthalmology contributed the articles for the Eye on AAO 2016 e-Bulletins, which feature conference highlights, reviews of hot topics discussed at the meeting, Asian and clinical relevance of few of the important topics.
At the 7th Annual Congress of the Malaysian Endocrine & Metabolic Society (MAC7), Professor Dr Chan Siew Pheng and Dr Gavin Tan spoke on the recent evidence to improve residual CV risk and DR respectively, in type 2 diabetes mellitus (T2DM). Highlights of their presentations are summarized below.
Eye on AAO 2015 is a series of daily e-Bulletins from the 2015 Annual Meeting of the American Academy of Ophthalmology which took place in Las Vegas, USA from 14–17 November 2015. These e-Bulletins feature reviews and opinions of presentations and workshops by an international panel of renowned clinicians in ophthalmology.
We hope you find the bulletins interesting and informative, adding to your knowledge of advances in ophthalmology, and supportive of your clinical practice endeavours. You can download copies of the e-Bulletins from this page.
In the treatment of proliferative diabetic retinopathy (DR), eyes gain vision and rarely develop vision-impairing central-involved diabetic macula oedema (DME) over 2 years with ranibizumab, according to a posthoc analysis. In contrast, factors such as poor glycaemic control and more severe DR increase the likelihood of losing visual acuity and developing DME following panretinal photocoagulation (PRP).